Detecting cancer gene networks characterized by recurrent genomic alterations in a population

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Efroni, Sol ^a   Ben Hamo, Rotem ^a   Edmonson, Michael ^b   Greenblum, Sharon ^b   Schaefer, Carl F ^c   Buetow, Kenneth H ^b,c  

^a BAR ILAN UNIVERSITY   (Israel)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; GENE DOSAGE; GENE EXPRESSION; HUMAN; BIOLOGY; BREAST TUMOR; COPY NUMBER VARIATION; FEMALE; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETICS; GENOMIC INSTABILITY; METHODOLOGY; NEOPLASM; RECURRENT DISEASE; SYSTEMS BIOLOGY; TECHNIQUE;

BREAST NEOPLASMS; COMPUTATIONAL BIOLOGY; DNA COPY NUMBER VARIATIONS; FEMALE; GENE REGULATORY NETWORKS; GENOME-WIDE ASSOCIATION STUDY; GENOMIC INSTABILITY; HUMANS; METHODS; NEOPLASMS; RECURRENCE; SYSTEMS BIOLOGY;

EID: 79251575559     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014437     Document Type: Article

References (50)

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
2. Mani KM, Lefebvre C, Wang K, Lim WK, Basso K, et al. (2008) A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas. Mol Syst Biol 4: 169.
3. Al-Kuraya K, Schraml P, Torhorst J, Tapia C, Zaharieva B, et al. (2004) Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Research 64: 8534-8540.
4. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, et al. (1994) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proceedings of the National Academy of Sciences of the United States of America 91: 2156-2160.
5. Kallioniemi OP, Kallioniemi A, Kurisu W, Thor A, Chen LC, et al. (1992) ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proceedings of the National Academy of Sciences of the United States of America 89: 5321-5325.
6. Loo LWM, Grove DI, Williams EM, Neal CL, Cousens LA, et al. (2004) Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes. Cancer Research 64: 8541-8549.
7. Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, et al. (2005) Highresolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization. Breast Cancer Res 7: R1186-R1198. doi:10.1186/bcr1356.
8. Pollack JR, Perou CM, Alizadeh AA, Eisen MB, Pergamenschikov A, et al. (1999) Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nature Genetics 23: 41-46.
9. Press MF, Sauter G, Bernstein L, Villalobos IE, Mirlacher M, et al. (2005) Diagnostic evaluation of HER-2 as a molecular target: An assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clinical Cancer Research 11: 6598-6607.
10. Tanner MM, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, et al. (1994) Increased copy number at 20q13 in breast cancer: Defining the critical region and exclusion of candidate genes. Cancer Research 54: 4257-4260.
11. Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, et al. (1994) Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A 91: 2156-2160.
12. Barlund M, Monni O, Kononen J, Cornelison R, Torhorst J, et al. (2000) Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. Cancer Research 60: 5340-5344.
13. Cheng KW, Lahad JP, Kuo WL, Lapuk A, Yamada K, et al. (2004) The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nature Medicine 10: 1251-1256.
14. Isola JJ, Kallioniemi OP, Chu LW, Fuqua SAW, Hilsenbeck SG, et al. (1995) Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. American Journal of Pathology 147: 905-911.
15. Jain AN, Chin K, Børresen-Dale AL, Erikstein BK, Lonning PE, et al. (2001) Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proceedings of the National Academy of Sciences of the United States of America 98: 7952-7957.
16. Pollack JR, Sørlie T, Perou CM, Rees CA, Jeffrey SS, et al. (2002) Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proceedings of the National Academy of Sciences of the United States of America 99: 12963-12968.
17. Ray ME, Yang ZQ, Albertson D, Kleer CG, Washburn JG, et al. (2004) Genomic and Expression Analysis of the 8p11-12 Amplicon in Human Breast Cancer Cell Lines. Cancer Research 64: 40-47.
18. Yi Y, Mirosevich J, Shyr Y, Matusik R, George AL, Jr. (2005) Coupled analysis of gene expression and chromosomal location. Genomics 85: 401-412.
19. Chin K, DeVries S, Fridlyand J, Spellman P, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541.
20. Feldman I, Rzhetsky A, Vitkup D (2008) Network properties of genes harboring inherited disease mutations. Proc Natl Acad Sci U S A 105: 4323-4328.
21. Edelman E, Porrello A, Guinney J, Balakumaran B, Bild A, et al. (2006) Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profiles. Bioinformatics 22: e108-116.
22. Barbie DA, Tamayo P, Boehm JS, Kim SY, Moody SE, et al. (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462: 108-U122.
23. Montaner D, Dopazo J (2010) Multidimensional gene set analysis of genomic data. PLoS One 5: e10348.
24. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, et al. (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10: 529-541.
25. Efroni S, Schaefer CF, Buetow KH (2007) Identification of key processes underlying cancer phenotypes using biologic pathway analysis. PLoS ONE 2: e425.
26. Hodgson G, Hager JH, Volik S, Hariono S, Wernick M, et al. (2001) Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet 29: 459-464.
27. Pinkel D, Segraves R, Sudar D, Clark S, Poole I, et al. (1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20: 207-211.
28. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, et al. (2001) Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 29: 263-264.
29. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, et al. (1997) Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20: 399-407.
30. Buetow KH, Klausner RD, Fine H, Kaplan R, Singer DS, et al. (2002) Cancer Molecular Analysis Project: weaving a rich cancer research tapestry. Cancer Cell 1: 315-318.
31. Strausberg RL, Buetow KH, Greenhut SF, Grouse LH, Schaefer CF (2002) The cancer genome anatomy project: online resources to reveal the molecular signatures of cancer. Cancer Invest 20: 1038-1050.
32. Schaefer CF (2007) Pathway Interaction Database National Cancer Institute & Nature Publishing Group.
33. Kopf E, Plassat JL, Vivat V, de The H, Chambon P, et al. (2000) Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acidinduced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. J Biol Chem 275: 33280-33288.
34. Schindler H, Lutz MB, Rollinghoff M, Bogdan C (2001) The production of IFNgamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J Immunol 166: 3075-3082.
35. Rincon M, Enslen H, Raingeaud J, Recht M, Zapton T, et al. (1998) Interferongamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J 17: 2817-2829.
36. Bhattacharya M, Ojha N, Solanki S, Mukhopadhyay CK, Madan R, et al. (2006) IL-6 and IL-12 specifically regulate the expression of Rab5 and Rab7 via distinct signaling pathways. EMBO J 25: 2878-2888.
37. Graves PR, Yu L, Schwarz JK, Gales J, Sausville EA, et al. (2000) The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01. J Biol Chem 275: 5600-5605.
38. Huang LE, Gu J, Schau M, Bunn HF (1998) Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A 95: 7987-7992.
39. Isaacs JS, Jung YJ, Neckers L (2004) Aryl hydrocarbon nuclear translocator (ARNT) promotes oxygen-independent stabilization of hypoxia-inducible factor- 1alpha by modulating an Hsp90-dependent regulatory pathway. J Biol Chem 279: 16128-16135.
40. Isaacs JS, Jung YJ, Mimnaugh EG, Martinez A, Cuttitta F, et al. (2002) Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alphadegradative pathway. J Biol Chem 277: 29936-29944.
41. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
42. Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, et al. (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98: 262-272.
43. Miller LD, Smeds J, George J, Vega VB, Vergara L, et al. (2005) An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 102: 13550-13555.
44. Cowell JK, Nowak NJ (2003) High-resolution analysis of genetic events in cancer cells using bacterial artificial chromosome arrays and comparative genome hybridization. Adv Cancer Res 90: 91-125.
45. Jeffrey SS, Pollack JR (2003) The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions. Breast Cancer Res 5: 320-328.
46. Mendrzyk F, Korshunov A, Benner A, Toedt G, Pfister S, et al. (2006) Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 12: 2070-2079.
47. Stange DE, Radlwimmer B, Schubert F, Traub F, Pich A, et al. (2006) Highresolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer. Clin Cancer Res 12: 345-352.
48. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
49. Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, et al. (2009) PID: the Pathway Interaction Database. Nucleic Acids Res 37: D674-679.
50. Fisher RA (1932) Statistical methods for research workers. Edinburgh: Oliver and Boyd. xiii, 319 p.